| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/01/2005 | EP1534250A2 Electrospun amorphous pharmaceutical compositions |
| 06/01/2005 | EP1448794A4 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis |
| 06/01/2005 | EP1416936B1 Thiopyrane-4-ones as dna protein kinase inhibitors |
| 06/01/2005 | EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1253904B1 Use of extracts from residues left in the production of wine as cosmetic care actives for skin and hair |
| 06/01/2005 | EP1233951B1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 06/01/2005 | EP1218064B1 COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASEs CONTAINING A COMPOUND WHICH INHIBITS ICAM-LFA-1 INTERACTION AND A COMPOUND WHICH INHIBITS CD40-CD40 LIGAND INTERACTION |
| 06/01/2005 | EP1207157B1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 06/01/2005 | EP1188754B1 Substituted pyrazole compounds |
| 06/01/2005 | EP1171160B1 Method and means for treating post-polio syndrome |
| 06/01/2005 | EP1119321B1 Patient temperature regulation method and apparatus |
| 06/01/2005 | EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 06/01/2005 | EP1100878B1 Process for producing genetically modified cd34-negative adherently growing haematopoietic stem cells |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 06/01/2005 | EP0906433B1 Protein tyrosine phosphatases of hematopoietic cells |
| 06/01/2005 | EP0794963B1 Xanthine derivatives compounds useful for activating chloride conductance in animal cells |
| 06/01/2005 | EP0769059B1 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 06/01/2005 | CN1623001A System for monitoring bacterial tumor treatment |
| 06/01/2005 | CN1622994A TGF-beta-specific covalently closed antisense molecule |
| 06/01/2005 | CN1622958A Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
| 06/01/2005 | CN1622957A IFNAR2 mutants, their production and use |
| 06/01/2005 | CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 06/01/2005 | CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 06/01/2005 | CN1622941A Glutaminyl based DPIV inhibitors |
| 06/01/2005 | CN1622937A Process for the manufacture of HMG-coa reductase inhibitors |
| 06/01/2005 | CN1622936A Process for the preparation of high purity perindopril and intermediates useful in the synthesis |
| 06/01/2005 | CN1622827A Thrombin derived peptides for promoting cardiac tissue repair |
| 06/01/2005 | CN1622822A Medicinal compositions containing ghrelin |
| 06/01/2005 | CN1622816A Composition and method for augmenting kidney function |
| 06/01/2005 | CN1622814A Use of antitumor indolopyrrolocarbazole derivative and other anticancer agent in combination |
| 06/01/2005 | CN1622807A Phenylpyrimidine amines as IgE inhibitors |
| 06/01/2005 | CN1622806A Method for the treatment of overactive bladder |
| 06/01/2005 | CN1622805A Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 06/01/2005 | CN1622754A Novel immune effect compound |
| 06/01/2005 | CN1621078A Traditional Chinese medicine composition for treating intelligence impairment and dementia and preparation method thereof |
| 06/01/2005 | CN1204258C Component of bromelain |
| 06/01/2005 | CN1204144C Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/01/2005 | CN1204143C Crystalline forms of EtO2C-CH2-(R)Cgl-Aze-Pab-OH |
| 06/01/2005 | CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs. |
| 06/01/2005 | CN1203898C Perfluoroalkyl-containing metal complexes, its preparing method and use in NMR diagnostics |
| 06/01/2005 | CN1203897C Sustained release salts of pharmaceutically active peptides and production thereof |
| 06/01/2005 | CN1203861C Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside Rb1 |
| 06/01/2005 | CN1203860C Application of Na-ion channel blocker and aspirin in preparing antalgic medicine for mammal |
| 06/01/2005 | CN1203852C Valdecoxib compositions |
| 06/01/2005 | CN1203775C Feed coposition for broilers and method for breeding broilers |
| 05/31/2005 | US6900367 Transgenic Drosophila melanogaster expressing a β42 in the eye |
| 05/31/2005 | US6900354 3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives |
| 05/31/2005 | US6900353 Cyclopentyl sulfonamide derivatives |
| 05/31/2005 | US6900344 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 05/31/2005 | US6900338 Scavenger compounds |
| 05/31/2005 | US6900329 MCH antagonists and their use in the treatment of obesity |
| 05/31/2005 | US6900318 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 05/31/2005 | US6900309 Aminocarbonylation reaction of a adenosine compound containing purine base and pentofuranosyl sugar and a leaving group at 2 position of purine ring, with an amine compound in presence of carbon monoxide and suitable coupling catalyst |
| 05/31/2005 | US6900307 Phenylsulfide derivatives with purine nucleic base containing amine or acyl substituent at 2-position of purine ring |
| 05/31/2005 | US6900243 Phenylheteroalkylamine derivatives |
| 05/31/2005 | US6900231 Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 05/31/2005 | US6900230 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents |
| 05/31/2005 | US6900229 Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amide |
| 05/31/2005 | US6900226 Quinoline and quinazoline derivatives; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 05/31/2005 | US6900221 Crystalline polymorph of erlotinib hydrochloride; synthesis; treating cancer |
| 05/31/2005 | US6900216 Psychological disorders; antidepressants; brain diosrders; anticonvulsants |
| 05/31/2005 | US6900211 CCR5 antagonists useful for treating aids |
| 05/31/2005 | US6900205 Antidiabetic agents |
| 05/31/2005 | US6900202 Nicotinic acetylcholine receptor activators; treating neurodegenerative disorders |
| 05/31/2005 | US6900201 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/31/2005 | US6900200 Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| 05/31/2005 | US6900199 Central nervous system disorders; prevention amyloid deposits; Alzheimer's disease; Down sydrome |
| 05/31/2005 | US6900198 Salen-metal complexes having superoxide activity, catalase activity, and/or peroxidase activity to treat or prevent a disease associated with cell or tissue damage produced by free radicals such as superoxide |
| 05/31/2005 | US6900194 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
| 05/31/2005 | US6900187 TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications |
| 05/31/2005 | US6900161 Azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 05/31/2005 | US6900055 Oxygen permeable biocompatible elastomer for propagating viable tissue; tissue engineering |
| 05/31/2005 | US6900031 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis |
| 05/31/2005 | US6900008 Methods and formulations for minimizing spasticity in blood vessel grafts |
| 05/31/2005 | US6899896 Hydrogel-driven layered drug dosage form |
| 05/31/2005 | US6899888 Suppressing bone disordes such as decalcification or fractures in humans having prostate gland cancers by administering antiestrogen selected from triphenylethylene or toremifene; hormone inhibitors |
| 05/31/2005 | US6899879 Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies |
| 05/31/2005 | US6899867 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 05/26/2005 | WO2005047256A1 The derivatives of pyridone and the use of them |
| 05/26/2005 | WO2005046612A2 Hydroxy piperidine derivatives to treat gaucher disease |
| 05/26/2005 | WO2005046611A2 Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| 05/26/2005 | WO2005046358A1 Method of using whole olive and food having activity against helicobacter pylori |
| 05/26/2005 | WO2005028438A9 Novel piperidine derivative |
| 05/26/2005 | WO2004083392A3 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 05/26/2005 | US20050114914 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies |
| 05/26/2005 | US20050113577 Such as hydrochloride salt 3-[5-(4-methanesulfonyl-piperazin-1-yl-methyl)-1H-indol-2-yl]-1H-quinolin-2-one; signal transduction; for treatment of angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, and inflammatory diseases |
| 05/26/2005 | US20050113451 7-acetamidinyl derivatives |
| 05/26/2005 | US20050113447 Selective retinoid agonists |
| 05/26/2005 | US20050113440 Compounds that modulate PPAR activity and methods for their preparation |
| 05/26/2005 | US20050113432 Bis(cyanophenyl)methyl-triazole for use in prevention of breast cancer |
| 05/26/2005 | US20050113430 2-[o-(aminoalkoxy)phenyl])-3-acylbenzothiazolines, e.g., 3-Acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)-propoxy)-5-methoxyphenyl]benzothiazoline; treating pruritus or pain, particularly that caused by a rheumatic disease |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 05/26/2005 | US20050113415 Promoting the activity of glucocerebrosidease by administering a reversible competitive inhibitor such as iminosugars, e.g. calysegnines, isofagomines,N-alkyl-deoxynojirimycins; lysosomal storage disorders |
| 05/26/2005 | US20050113412 Quinoline compounds and their uses |
| 05/26/2005 | US20050113402 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 05/26/2005 | US20050113384 Combinations of (a) an atp-competitive inhibitor of c-acl kinase activity with (b) two or more other antineoplastic agents |
| 05/26/2005 | US20050113383 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 05/26/2005 | US20050113378 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis |